Lecanemab

Area of Science:

• Pharmacology
• Drug Information Services
• Health-System Pharmacy

Background:

• Pharmacy & Therapeutics (P&T) Committees require timely and accurate drug information.
• Evaluating new and investigational drugs is crucial for formulary management.
• Effective drug utilization reviews (DURs) and medication use evaluations (MUEs) are essential for patient safety and cost-effectiveness.

Purpose of the Study:

• To introduce The Formulary Monograph Service as a resource for P&T Committees.
• To highlight the service's provision of detailed monographs on new and late-phase trial drugs.
• To inform about supplementary resources like summary monographs and DUE/MUEs.

Main Methods:

• The service delivers 5-6 detailed monographs monthly on drugs in early release or Phase III trials.
• One-page summary monographs are provided for pharmacy and nursing in-service needs.
• Comprehensive drug utilization evaluation/medication use evaluation (DUE/MUE) reports are included.

Main Results:

• Subscribers gain access to well-documented drug information.
• Resources are tailored for P&T Committee agendas and staff education.
• Online access and customization options enhance usability for healthcare facilities.

Conclusions:

• The Formulary Monograph Service supports evidence-based formulary decisions.
• It facilitates efficient drug evaluation and medication use monitoring.
• The service enhances pharmacy practice through accessible, relevant drug information.